Mouse Monoclonal ERp57 antibody. Suitable for Flow Cyt, WB, IHC-P, ICC/IF and reacts with Human, Mouse samples. Cited in 49 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human PDIA3.
View Alternative Names
ERP57, ERP60, GRP58, PDIA3, Protein disulfide-isomerase A3, 58 kDa glucose-regulated protein, 58 kDa microsomal protein, Disulfide isomerase ER-60, Endoplasmic reticulum resident protein 57, Endoplasmic reticulum resident protein 60, p58, ER protein 57, ERp57, ER protein 60, ERp60
- Flow Cyt
Unknown
Flow Cytometry - Anti-ERp57 antibody [MaP.Erp57] (AB13506)
Overlay histogram showing HeLa cells stained with ab13506 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab13506, 2μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells ) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HeLa cells fixed with 4% paraformaldehyde (10 min)/permeabilized in 0.1% PBS-Tween used under the same conditions.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-ERp57 antibody [MaP.Erp57] (AB13506)
HaCaT (Human keratinocyte cell line) cells labeling ERp57 using ab13506 at 1/100 dilution in ICC.IF. Cells were fixed using 100% methanol for 10 minutes at -20°C and incubated with primary antibody for 1 hour at room temperature. Secondary antibody is a FITC-conjugated goat anti-mouse (green) incubated at 1/50 dilution for 1 hour at room temperature.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ERp57 antibody [MaP.Erp57] (AB13506)
Paraffin-embedded mouse backskin tissue ficed with Bouin's fixative, stained for ERp57 using ab13506 at 1/100 dilution in ICC/IF. Primary antibody was incubated for 1 hour at room temperature. Secondary antibody is a FITC-conjugated goat anti-mouse (green) incubated at 1/50 dilution for 1 hour at room temperature.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-ERp57 antibody [MaP.Erp57] (AB13506)
ICC/IF image of ab13506 stained HeLa cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody ab13506 at 5μg/ml overnight at +4°C. The secondary antibody (green) was DyLight® 488 goat anti- mouse (ab96879) IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.
- WB
Lab
Western blot - Anti-ERp57 antibody [MaP.Erp57] (AB13506)
Lane 1 : Wild-type HAP1 whole cell lysate (20 μg)
Lane 2 : ERp57 knockout HAP1 whole cell lysate (20 μg)
Lane 3 : HepG2 whole cell lysate (20 μg)
Lane 4 : HEK293 whole cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab13506 observed at 57 kDa. Red - loading control, ab181602, observed at 37 kDa.
ab13506 was shown to specifically react with ERp57 in wild-type HAP1 cells as signal was lost in ERp57 knockout cells. Wild-type and ERp57 knockout samples were subjected to SDS-PAGE. ab13506 and ab181602 (Rabbit anti-GAPDH loading control) were incubated overnight at 4°C at 0.5 μg/ml and 1/20000 dilution respectively. Blots were developed with Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed ab216772 and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed ab216777 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-ERp57 antibody [MaP.Erp57] (ab13506)
Predicted band size: 57 kDa
false
- WB
AbReview19171****
Western blot - Anti-ERp57 antibody [MaP.Erp57] (AB13506)
ERp57 antibody (ab13506) at 1/1000 dilution (in PBST) for 8 hours at 4°C + lysate of mouse of pancreatic cancer cell line at 25 μg.
Secondary
An HRP conjugated Sheep anti-mouse IgG polyclonal at 1/5000 dilution
developed using the ECL technique
Performed under non-reducing conditions.
Exposure time : 1 minute
Blocking Step : 10% Milk for 1 hour at room temperature.
All lanes:
Western blot - Anti-ERp57 antibody [MaP.Erp57] (ab13506)
Predicted band size: 57 kDa
Observed band size: 61 kDa
false
This image is courtesy of an Abreview submitted by Pawel Mazur
Related conjugates and formulations (1)
-
519 FITC
FITC Anti-ERp57 antibody [Map.ERP57]
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ERp57 interacts with calnexin and calreticulin to form a complex involved in glycoprotein folding. This complex assists in the proper assembly and maturation of nascent glycoproteins by ensuring correct folding pathways within the cell. ERp57 has a specialized role in managing oxidative protein folding which makes it essential for cell function and homeostasis.
Pathways
ERp57 participates in the calnexin/calreticulin cycle which is critical for protein triage in the endoplasmic reticulum. This cycle ensures that only properly folded proteins progress to their final destinations. ERp57 also interacts with ERp72 another member of the PDI family to facilitate thiol-disulfide exchange reactions. These interactions position ERp57 as a central player in the maintenance of cellular redox balance and protein homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (49)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:2535 PubMed40087276
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of Cancer 16:1215-1227 PubMed39895780
2025
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 19:e0308821 PubMed39316592
2024
Applications
Unspecified application
Species
Unspecified reactive species
eLife 13: PubMed38900146
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy : the journal of the American Society of Gene Therapy 32:2778-2797 PubMed38822524
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 15: PubMed38136312
2023
Applications
Unspecified application
Species
Unspecified reactive species
Respiratory research 24:83 PubMed36927357
2023
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 298:102677 PubMed36336075
2022
Applications
Unspecified application
Species
Unspecified reactive species
Shock (Augusta, Ga.) 58:556-564 PubMed36374735
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular gastroenterology and hepatology 15:197-211 PubMed36122677
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com